Mobile Phones Being Used During Heart Surgery

Possibly a place where mobile phones might be thought to be banned, turns out to be a hotbed of phone use - the hospital operating theatre.

A survey of the professionals who operates the heart-lung machine during cardiac surgery found that over half (55.6%) of perfusionists use of a cell phone during the performance of cardiopulmonary bypass (CPB).

Sending text messages while performing CPB was acknowledged by 49.2%, with clear generational differences detected when cross-referenced with age groups. For smart phone features, perfusionists report having accessed e-mail (21%), used the internet (15.1%), or have checked/posted on social networking sites (3.1%) while performing heart surgery.

Despite this, safety concerns were expressed by 78.3% who believe that cell phones can introduce a potentially significant safety risk to patients.

Speaking on a cell phone and text messaging during CPB are regarded as "always an unsafe practice" by 42.3% and 51.7% of respondents, respectively. Personal distraction by cell phone use that negatively affected performance was admitted by 7.3%, whereas witnessing another perfusionist distracted with phone/text while on CPB was acknowledged by 33.7% of respondents.

This survey suggests that the majority of perfusionists believe cell phones raise significant safety issues while operating the heart-lung machine. However, the majority also have used a cell phone while performing this activity. There are clear generational differences in opinions on the role and/or appropriateness of cell phones during bypass. There is a need to further study this issue and, perhaps, to establish consensus on the use of various communication modes within the perfusion community.

Methodology

In October 2010, a link to a 19-question survey (surveymonkey.com) was posted on the AmSECT (PerfList) and Perfusion.com (PerfMail) forums. There were 439 respondents. Demographic distribution is as follows; Chief Perfusionist (30.5%), Staff Perfusionist (62.0%), and Other (7.5%), with age ranges of 20-30 years (14.2%), 30-40 years (26.5%), 40-50 years (26.7%), 50-60 years (26.7%), >60 years (5.9%).

The results of the survey were presented at the 32nd Annual Seminar of The American Academy of Cardiovascular Perfusion, Reno, Nevada, 27-30, January, 2011.